Jean-Michel Pawlotsky. Show Affiliations »
Abstract
Mesh： See more » Antiviral Agents/therapeutic useDrug Therapy, CombinationFollow-Up StudiesHepacivirus/drug effectsHepacivirus/geneticsHepacivirus/pathogenicityHepatitis C/drug therapyHepatitis C/virologyHumansInterferon alpha-2Interferon-alpha/therapeutic useProline/analogs & derivativesProline/therapeutic useRNA, Viral/analysisRecombinant ProteinsTreatment Outcome
Substances： See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRNA, ViralRecombinant ProteinsN-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamideProline
Year: 2007 PMID： 17418174 DOI： 10.1053/j.gastro.2007.03.014
Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682